0 companies ↑↓ to move Enter to open Esc to close
INTEL CORP
Export XLSX
| USD ($) $ in Millions | Dec 27, 2025 | Dec 28, 2024 | Dec 30, 2023 | Dec 31, 2022 | Dec 25, 2021 | Dec 26, 2020 | Dec 28, 2019 | Dec 29, 2018 | Dec 30, 2017 | Dec 31, 2016 | Dec 26, 2015 | Dec 27, 2014 | Dec 28, 2013 | Dec 29, 2012 | Dec 31, 2011 | Dec 25, 2010 | Dec 26, 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flows provided by (used for) operating activities: | |||||||||||||||||
Net income (loss) | $ 26 | $ (19,233) | $ 1,675 | ||||||||||||||
Net income | - | - | - | ||||||||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||
Depreciation | 10,757 | 9,951 | 7,847 | ||||||||||||||
Share-based compensation | 2,434 | 3,410 | 3,229 | ||||||||||||||
Restructuring and other charges | 476 | 3,491 | (424) | ||||||||||||||
Restructuring, asset impairment, and net loss on retirement of assets | - | - | - | ||||||||||||||
Excess tax benefit from share-based payment arrangements | - | - | - | ||||||||||||||
Amortization of intangibles | 949 | 1,428 | 1,755 | ||||||||||||||
(Gains) losses on equity investments, net | (514) | (246) | (42) | ||||||||||||||
Mark-to-market (gains) losses on Escrowed Shares | 1,796 | - | - | ||||||||||||||
Gain (Loss) on Sale of Equity Investments | - | - | - | ||||||||||||||
Loss on debt conversion and extinguishment | - | - | - | ||||||||||||||
Amortization of intangibles and other acquisition-related costs | - | - | - | ||||||||||||||
(Gains) losses on equity method investments, net | - | - | - | ||||||||||||||
(Gains) losses on other equity investments, net | - | - | - | ||||||||||||||
(Gains) losses on divestitures | (5,323) | 0 | 0 | ||||||||||||||
Deferred taxes | 328 | 6,132 | - | ||||||||||||||
Impairments and net (gain) loss on retirement of property, plant and equipment | 515 | 2,252 | - | ||||||||||||||
Changes in assets and liabilities: | |||||||||||||||||
Trading assets | - | - | - | ||||||||||||||
Accounts receivable | (449) | (75) | 731 | ||||||||||||||
Inventories | (138) | (1,105) | 2,097 | ||||||||||||||
Accounts payable | 297 | 634 | (801) | ||||||||||||||
Accrued compensation and benefits | 788 | (218) | (614) | ||||||||||||||
Customer deposits and prepaid supply agreements | - | - | 0 | ||||||||||||||
Income taxes | (995) | (356) | (3,531) | ||||||||||||||
Other assets and liabilities | (1,250) | 2,223 | (451) | ||||||||||||||
Total adjustments | 9,671 | 27,521 | 9,796 | ||||||||||||||
Net cash provided by (used for) operating activities | 9,697 | 8,288 | 11,471 | ||||||||||||||
Cash flows provided by (used for) investing activities: | |||||||||||||||||
Additions to property, plant and equipment | (14,646) | (23,944) | (25,750) | ||||||||||||||
Additions to held for sale NAND property, plant, and equipment | - | - | 0 | ||||||||||||||
Proceeds from capital-related government incentives | 1,577 | 1,936 | 1,011 | ||||||||||||||
Acquisitions, net of cash acquired | - | (82) | - | ||||||||||||||
Purchases of short-term investments | (24,319) | (37,940) | (44,414) | ||||||||||||||
Maturities and sales of short-term investments | 15,387 | 41,463 | 44,077 | ||||||||||||||
Purchases of available-for-sale investments | - | - | - | ||||||||||||||
Sales of available-for-sale investments | - | - | - | ||||||||||||||
Maturities and sales of available-for-sale debt investments | - | - | - | ||||||||||||||
Maturities and sales of available-for-sale investments | - | - | - | ||||||||||||||
Purchases of trading assets | - | - | - | ||||||||||||||
Maturities and sales of trading assets | - | - | - | ||||||||||||||
Investments in loans receivable and reverse repurchase agreements | - | - | - | ||||||||||||||
Collection of loans receivable and reverse repurchase agreements | - | - | - | ||||||||||||||
Purchases of equity investments | - | - | (399) | ||||||||||||||
Sales of equity investments | 671 | 1,047 | 472 | ||||||||||||||
Return of equity method investments | - | - | - | ||||||||||||||
Proceeds from Divestiture of Businesses | 6,157 | 0 | 0 | ||||||||||||||
Collection of loans receivable | - | - | - | ||||||||||||||
Origination of loans receivable | - | - | - | ||||||||||||||
Investments in non-marketable equity investments | - | - | - | ||||||||||||||
Purchases of licensed technology and patents | - | - | - | ||||||||||||||
Other investing | 352 | (736) | 962 | ||||||||||||||
Net cash provided by (used for) investing activities | (14,821) | (18,256) | (24,041) | ||||||||||||||
Cash flows provided by (used for) financing activities: | |||||||||||||||||
Issuance of commercial paper, net of issuance costs | 3,493 | 7,349 | 0 | ||||||||||||||
Repayment of commercial paper | (3,493) | (7,349) | (3,944) | ||||||||||||||
Payments on finance leases | - | - | (96) | ||||||||||||||
Partner contributions | 5,108 | 12,714 | 1,511 | ||||||||||||||
Net proceeds from sales of subsidiary shares | 921 | 0 | 2,959 | ||||||||||||||
Additions to property, plant and equipment | (3,026) | (1,178) | - | ||||||||||||||
Proceeds from (Repayments of) Short-term Debt | - | - | - | ||||||||||||||
Proceeds from government grants | - | - | - | ||||||||||||||
Excess tax benefit from share-based payment arrangements | - | - | - | ||||||||||||||
Issuance of long-term debt, net of issuance costs | 0 | 2,975 | 11,391 | ||||||||||||||
Repayment of debt | (3,750) | (2,288) | (423) | ||||||||||||||
Proceeds from sales of common stock through employee equity incentive plans | 771 | 987 | 1,042 | ||||||||||||||
Net proceeds attributed to common stock and warrants issued, and Escrowed Shares | 12,706 | - | - | ||||||||||||||
Restricted stock unit withholdings | (423) | (631) | - | ||||||||||||||
Repurchase of common stock | - | - | 0 | ||||||||||||||
Payment of dividends to stockholders | 0 | (1,599) | (3,088) | ||||||||||||||
Collateral associated with repurchase of common stock | - | - | - | ||||||||||||||
Increase (decrease) in liability due to collateral associated with repurchase of common stock | - | - | - | ||||||||||||||
Increase in liability due to collateral associated with repurchase of common stock | - | - | - | ||||||||||||||
Other financing | (720) | 158 | (847) | ||||||||||||||
Net cash provided by (used for) financing activities | 11,587 | 11,138 | 8,505 | ||||||||||||||
Net increase (decrease) in cash and cash equivalents | 6,463 | 1,170 | (4,065) | ||||||||||||||
Effect of exchange rate fluctuations on cash and cash equivalents | - | - | - | ||||||||||||||
Non-cash supplemental disclosures: | |||||||||||||||||
Acquisition of property, plant and equipment | 4,952 | 8,125 | 4,804 | ||||||||||||||
Transfer to Investments | - | - | - | ||||||||||||||
Cash paid during the year for: | |||||||||||||||||
Interest, net of capitalized interest | 1,106 | 987 | 613 | ||||||||||||||
Income taxes, net of refunds | - | $ 2,202 | $ 2,621 |